TrialInternational journal of hematology2024

Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera.

Keita Kirito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.